Addex Therapeutics (ADXN) Treasury Shares (2022 - 2024)
Historic Treasury Shares for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $992790.7.
- Addex Therapeutics' Treasury Shares fell 318.05% to $992790.7 in Q4 2024 from the same period last year, while for Dec 2024 it was $992790.7, marking a year-over-year decrease of 318.05%. This contributed to the annual value of $988598.5 for FY2024, which is 238.48% down from last year.
- Per Addex Therapeutics' latest filing, its Treasury Shares stood at $992790.7 for Q4 2024, which was down 318.05% from $1.0 million recorded in Q4 2023.
- Over the past 5 years, Addex Therapeutics' Treasury Shares peaked at $6.5 million during Q4 2022, and registered a low of $992790.7 during Q4 2024.
- In the last 3 years, Addex Therapeutics' Treasury Shares had a median value of $1.0 million in 2023 and averaged $2.8 million.
- Per our database at Business Quant, Addex Therapeutics' Treasury Shares plummeted by 8426.69% in 2023 and then plummeted by 318.05% in 2024.
- Quarter analysis of 3 years shows Addex Therapeutics' Treasury Shares stood at $6.5 million in 2022, then crashed by 84.27% to $1.0 million in 2023, then decreased by 3.18% to $992790.7 in 2024.
- Its last three reported values are $992790.7 in Q4 2024, $1.0 million for Q4 2023, and $6.5 million during Q4 2022.